Search Results By Year:
Showing 196 - 205 of 205 results
  • Onitilo AA. Social costs and medical benefits of genetic information on sickle-cell disease. Pugwash Guidebook. 1994;
  • Schifeling DJ, Jackson DV, Zekan PJ, Muss HB. Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology Association. Am J Clin Oncol. 1992 Jun;15(3):233-235.
    PubMed ID: 1590276
  • Schifeling DJ, Konski AA, Howard JM, Dobelbower RR, Merrick HW, Skeel RT. Radiation therapy and 5-fluorouracil modulated by leucovorin for adenocarcinoma of the pancreas. A phase I study. Int J Pancreatol. 1992 Dec;12(3):239-243.
    PubMed ID: 1289417
  • Dobelbower RR, Konski AA, Merrick HW, Bronn DG, Schifeling DJ, Kamen C. Intraoperative electron beam radiation therapy (IOEBRT) for carcinoma of the exocrine pancreas. Int J Radiat Oncol Biol Phys. 1991 Jan;20(1):113-119.
    PubMed ID: 1899657
  • Schifeling DJ, Hamblin JE. Early diagnosis of breast cancer. Universal screening is essential. Postgrad Med. 1991 Feb;89(3):55-56, 59-60, 62.
    PubMed ID: 1994358
  • Schifeling DJ. Carcinomas of the pancreas, liver, gallbladder and bile ducts..
  • Bitran JD, Desser R, Schifeling DJ, Shapiro C, Kozloff MF, Robin E, Recant W, Michel A, Rochman H, Billings A. Multimodality therapy of stage III adenocarcinoma of the breast. Journal of Surgical Oncology. 1983 Jan;22(1):5-8.
    PubMed ID: 6687399
  • Gao M, Albuquerque K, Chi A, Rusu I. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy. Brachytherapy. 9(1):55-60.
    PubMed ID: 19853536
  • Chi A, Yu J, Rojanasakol Y, Monga M, Tse W, Remick S. Acquired resistance to EGFR inhibition in non-small cell lung cancer. Minerva Pneumologica. 53 :9-14.
  • Nguyen NP, Vock J, Vinh-Hung V, Khan R, Slane B, Sroka T, Jang S, Dias V, Vo RA, Karlsson U, Chi A. Feasibility of tomotherapy for postoperative irradiation of lower extremity sarcomas. Tumori. 100(4):466-9.
    PubMed ID: 25296598